Do you have a link confirming that. I thought someone posted here recently that this request had been turned down by the FDA - there was a quote for one of Nadar's update conference calls suggesting that. If you are right, that is very good news for CYDY as it will give them a combo market in which they will have a chance of serving a serious number of patients.
News 
Market Data 
Discover 
AI
